Teacher Retirement System of Texas Has $3.15 Million Stock Holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN)

Teacher Retirement System of Texas lowered its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 37.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,626 shares of the company's stock after selling 25,753 shares during the quarter. Teacher Retirement System of Texas' holdings in Ryan Specialty were worth $3,149,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. GAMMA Investing LLC increased its stake in shares of Ryan Specialty by 21.8% in the first quarter. GAMMA Investing LLC now owns 2,101 shares of the company's stock worth $155,000 after acquiring an additional 376 shares during the last quarter. CIBC Private Wealth Group LLC grew its position in Ryan Specialty by 6,911.0% in the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after purchasing an additional 774,718 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Ryan Specialty by 3.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,215 shares of the company's stock valued at $902,000 after purchasing an additional 460 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in Ryan Specialty by 982.1% during the fourth quarter. Jones Financial Companies Lllp now owns 1,450 shares of the company's stock valued at $93,000 after purchasing an additional 1,316 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Ryan Specialty by 3.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 974,451 shares of the company's stock valued at $62,521,000 after acquiring an additional 36,264 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director David P. Bolger sold 5,000 shares of the firm's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director owned 71,467 shares of the company's stock, valued at $5,059,863.60. This trade represents a 6.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the sale, the executive vice president owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their position. The disclosure for this sale can be found here. Company insiders own 52.21% of the company's stock.

Analyst Ratings Changes

RYAN has been the topic of several recent research reports. Wells Fargo & Company decreased their price target on Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a report on Thursday. TD Cowen started coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Morgan Stanley raised their target price on shares of Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Barclays cut their price objective on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating for the company in a research report on Monday. Finally, Keefe, Bruyette & Woods cut their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $75.00.

Ryan Specialty Price Performance

NYSE:RYAN traded down $1.58 during mid-day trading on Thursday, reaching $64.64. The stock had a trading volume of 831,672 shares, compared to its average volume of 923,794. Ryan Specialty Holdings Inc. has a 12 month low of $55.67 and a 12 month high of $77.16. The stock has a market capitalization of $16.96 billion, a PE ratio of 190.12, a P/E/G ratio of 1.76 and a beta of 0.66. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05. The stock has a 50-day simple moving average of $68.14 and a two-hundred day simple moving average of $68.11.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts' consensus estimates of $0.39. The company had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. Ryan Specialty's revenue was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.35 EPS. On average, equities analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were issued a $0.12 dividend. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.74%. Ryan Specialty's dividend payout ratio (DPR) is currently 141.18%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.